Key result
Inhibition of miR-429 expression promoted the expressions of ZO-1, Occludin, and Claudin-5 proteins in microvascular endothelial cells, improving BSCB permeability due to hypoxia.
Why the study?
To provide a new gene therapy target for enhancing the spinal cord microenvironment.
Inhibition of miR-429 improves blood spinal cord barrier permeability under hypoxia by upregulating tight junction proteins in vitro.
Answers are grounded in this paper and cite their sources.
miR-429 inhibition may preserve BSCB integrity in hypoxia; hypothesis-generating in vitro and requires in vivo validation.
OBJECTIVE: , and provide a new gene therapy target for enhancing the spinal cord microenvironment. METHODS: was measured by horseradish peroxidase (HRP) permeability. Real-time fluorescence quantitative PCR, Western blot, and immunofluorescence staining were used to observe the expressions of ZO-1, Occludin, and Claudin-5. Immunofluorescence staining showed that the immunofluorescence of ZO-1, Occudin, and Claudin-5 at the cell membrane boundary in group D were stronger than those in groups B and C, but not as strong as that in group A. CONCLUSION: Inhibition of miR-429 expression can promote the expressions of ZO-1, Occludin, and Claudin-5 proteins in microvascular endothelial cells, thereby improving the increased permeability of BSCB due to hypoxia.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2020) studied Increased permeability of blood spinal cord barrier due to hypoxia. Inhibition of miR-429 expression was evaluated on Expressions of ZO-1, Occludin, and Claudin-5 proteins and permeability of BSCB (p=>0.05). Inhibition of miR-429 expression promoted the expressions of ZO-1, Occludin, and Claudin-5 proteins in microvascular endothelial cells, improving BSCB permeability due to hypoxia.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: